Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Pepin

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
The AAPS Journal|November 27, 2020
Correction to: Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry PerspectiveArian Emami Riedmaier, Kevin DeMent, James Huckle, et al.
The AAPS Journal|September 27, 2020
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry PerspectiveArian Emami Riedmaier, Kevin DeMent, James Huckle, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.
Molecular Pharmaceutics|December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop ReportChrister Tannergren, Sumit Arora, Andrew Babiskin, et al.
Molecular Pharmaceutics|July 1, 2024
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary ReportXavier Pepin, Sumit Arora, Luiza Borges, et al.
Molecular Pharmaceutics|September 30, 2024
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary ReportTycho Heimbach, Flora Musuamba Tshinanu, Kimberly Raines, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2016
IMI - oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compoundsAlison Margolskee, Adam S Darwich, Xavier Pepin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 4, 2016
IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classesAdam S Darwich, Alison Margolskee, Xavier Pepin, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
The AAPS Journal|November 27, 2020
Correction to: Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry PerspectiveArian Emami Riedmaier, Kevin DeMent, James Huckle, et al.
The AAPS Journal|September 27, 2020
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry PerspectiveArian Emami Riedmaier, Kevin DeMent, James Huckle, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.
Molecular Pharmaceutics|December 16, 2024
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop ReportChrister Tannergren, Sumit Arora, Andrew Babiskin, et al.
Molecular Pharmaceutics|July 1, 2024
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary ReportXavier Pepin, Sumit Arora, Luiza Borges, et al.
Molecular Pharmaceutics|September 30, 2024
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary ReportTycho Heimbach, Flora Musuamba Tshinanu, Kimberly Raines, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2016
IMI - oral biopharmaceutics tools project - evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compoundsAlison Margolskee, Adam S Darwich, Xavier Pepin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 4, 2016
IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classesAdam S Darwich, Alison Margolskee, Xavier Pepin, et al.
Pageof 4